Počet záznamov: 1
HMG CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase inhibitors
SYS c006383 LBL ^^^^^nam--2200000-a-4500 005 20250607095528.6 008 940325s1990----xxu-----------100-0-engo- 040 $a BA006 $b slo 041 0-
$a eng 044 $a xxu $c US 080 $a 616.153.915(547.922):615.272.4.03(061.3) $2 1. stred. 245 10
$a HMG CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase inhibitors : $b <a> five year clinical perspective / $c S. M. Grundy (ed.) : symposium, November 12, 1989, New Orleans, Louisiana 264 -1
$a Washington : $b Reed, $c 1990 300 $a 55 s. 490 1-
$a American Journal of Cardiology $v [Supl.] 650 -2
$7 sllk_us_auth*d008148 $a lovastatín $x farmakológia $2 mesh 650 -2
$7 sllk_us_auth*d003226 $a kongresy ako téma $y Spojené štáty americké $y Louisiana $2 mesh 650 -2
$7 sllk_us_auth*d006903 $a hydroxymetylglutaryl-CoA-reduktázy $x antagonisty a inhibítory $x farmakológia $2 mesh 650 -2
$7 sllk_us_auth*d006937 $a hypercholesterolémia $x farmakoterapia $2 mesh 650 -2
$7 sllk_us_auth*d006937 $a hypercholesterolémia $2 mesh 700 1-
$7 sllk_us_auth*p0015596 $a Grundy, S. M. $q (Scott M.) $4 edt 830 -0
$7 sllk_us_cat*s003258 $a American Journal of Cardiology
Počet záznamov: 1